Mizuho Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Mizuho Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$239K	Sell	1,953 -993	-34%	-$128K	0.05%	250
2016 Q2	$344K	Buy	2,946 +1,592	+118%	+$226K	0.06%	244
2016 Q1	$235K	Sell	1,354 -1,434	-51%	-$211K	0.06%	207
2015 Q4	$532K	Buy	2,788 +421	+18%	+$73.5K	0.11%	178
2015 Q3	$370K	Buy	2,367 +592	+33%	+$108K	0.08%	195
2015 Q2	$321K	Buy	1,775 +421	+31%	+$72.7K	0.08%	204
2015 Q1	$235K	Buy	1,354 +423	+45%	+$76.6K	0.06%	207
2014 Q4	$172K	Buy	931 +220	+31%	+$40.8K	0.05%	201
2014 Q3	$118K	Buy	711 +270	+61%	+$44.3K	0.03%	214
2014 Q2	$69K	Hold	441	–	–	0.02%	275
2014 Q1	$67K	Hold	441	–	–	0.01%	247
2013 Q4	$59K	Hold	441	–	–	0.01%	256
2013 Q3	$51K	Hold	441	–	–	0.01%	275
2013 Q2	$41K	Buy	+441	New	+$42.5K	0.01%	298

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Mizuho Asset Management's ALXN Position: Q3 2016 in Review

Mizuho Asset Management reduced its Alexion Pharmaceuticals (ALXN) stake by 34% in Q3 2016, selling an estimated $128K and leaving 1,953 shares worth $239K. The position accounts for 0.05% of the portfolio, ranked #250.

Mizuho Asset Management first reported a position in ALXN in Q2 2013 and has held it in 14 quarters since. The position peaked at $532K in Q4 2015. 518 funds tracked by Wall St. Rank hold ALXN as of Q3 2016.

Mizuho Asset Management held 1,953 shares of Alexion Pharmaceuticals worth $239K as of Q3 2016.
Mizuho Asset Management sold 993 Alexion Pharmaceuticals shares in Q3 2016, an estimated $128K.
Alexion Pharmaceuticals made up 0.05% of Mizuho Asset Management's portfolio in Q3 2016, its #250 holding.
Mizuho Asset Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
Mizuho Asset Management's Alexion Pharmaceuticals position peaked at $532K in Q4 2015.
518 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.